Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
30
Number of overlapping holdings
22.1%
% of XBI's 136 holdings also in CNCR
41.7%
% of CNCR's 72 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
BLUEPRINT MEDICINES CORP. | 1.7% | 1.7% | 1.7% |
|
EXELIXIS INC | 1.2% | 2.0% | 1.2% |
|
REVOLUTION MEDICINES, INC. | 1.2% | 1.6% | 1.2% |
|
REGENERON PHARMACEUTICALS | 1.7% | 1.0% | 1.0% |
|
GERON CORP | 0.9% | 1.4% | 0.9% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to CNCR
|
NATERA INC | 3.5% |
|
GILEAD SCIENCES INC | 3.0% |
|
INCYTE CORP | 2.9% |
|
UNITED THERAPEUTICS CORP | 2.9% |
|
ADVENTRX PHARMACEUTICALS INC | 2.8% |
|
NEUROCRINE BIOSCIENCES INC | 2.8% |
|
SAREPTA THERAPEUTICS INC | 2.7% |
|
INSMED INC | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.6% |
|
EXACT SCIENCES CORP | 2.5% |
XBI Underweight Relative to CNCR
|
RECURSION PHARMACEUTICALS, INC CLASS | -2.6% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -2.4% |
|
MONTE ROSA THERAPEUTICS, INC. | -2.1% |
|
BRISTOL-MYERS SQUIBB CO | -1.8% |
|
MERSANA THERAPEUTICS, INC. | -1.7% |
|
REPLIMUNE GROUP, INC. | -1.7% |
|
SCHRODINGER, INC. | -1.7% |
|
ENLIVEN THERAPEUTICS, INC. | -1.6% |
|
ZYMEWORKS INC. | -1.6% |
|
XENCOR INC | -1.6% |